Page 5 of 5 – SEC Filing SIGNATURE After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct. The Baupost Group, L.L.C.
Date:
April 09, 2018 By:
/s/
Seth A. Klarman
Name: Seth A. Klarman
Title:
Partner and Chief Executive Officer
Baupost Group GP, L.L.C.
Date:
April 09, 2018 By:
/s/
Seth A. Klarman
Name: Seth A. Klarman
Title:
Managing Member
Seth A. Klarman
Date:
April 09, 2018 By:
/s/
Seth A. Klarman
Name: Seth A. Klarman
Footnotes: Item 3, Item 4 and Item 7
This statement on Schedule 13G is being jointly filed by The Baupost Group, L.L.C. (“Baupost”), Baupost Group GP, L.L.C. (“BG GP”) and Seth A. Klarman. Baupost is a registered investment adviser and acts as an investment adviser and general partner to various private investment limited partnerships. Securities reported on this statement on Schedule 13G as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships. BG GP, as the Manager of Baupost, and Mr. Klarman, as the sole owner and Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost.
Pursuant to Rule 13d-4, Seth A. Klarman and BG GP declare that the filing of this statement on Schedule 13G shall not be deemed an admission by either or both of them that they are, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this statement on Schedule 13G.
Attention: Intentional
misstatements or omissions of fact constitute Federal criminal violations (See
18 U.S.C. 1001)
Follow Cascadian Therapeutics Inc. (NASDAQ:CASC)
Follow Cascadian Therapeutics Inc. (NASDAQ:CASC)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.
| The Baupost Group, L.L.C. | |||
| Date: April 09, 2018 | By: | /s/ Seth A. Klarman | |
Name: Seth A. Klarman | |||
Title: Partner and Chief Executive Officer | |||
| Baupost Group GP, L.L.C. | |||
| Date: April 09, 2018 | By: | /s/ Seth A. Klarman | |
Name: Seth A. Klarman | |||
Title: Managing Member | |||
| Seth A. Klarman | |||
| Date: April 09, 2018 | By: | /s/ Seth A. Klarman | |
Name: Seth A. Klarman | |||
| Footnotes: | Item 3, Item 4 and Item 7 This statement on Schedule 13G is being jointly filed by The Baupost Group, L.L.C. (“Baupost”), Baupost Group GP, L.L.C. (“BG GP”) and Seth A. Klarman. Baupost is a registered investment adviser and acts as an investment adviser and general partner to various private investment limited partnerships. Securities reported on this statement on Schedule 13G as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships. BG GP, as the Manager of Baupost, and Mr. Klarman, as the sole owner and Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Pursuant to Rule 13d-4, Seth A. Klarman and BG GP declare that the filing of this statement on Schedule 13G shall not be deemed an admission by either or both of them that they are, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this statement on Schedule 13G. |
| Attention: | Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) |
Follow Cascadian Therapeutics Inc. (NASDAQ:CASC)
Follow Cascadian Therapeutics Inc. (NASDAQ:CASC)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
